Table 2. Daily nutrition intake and steps walked in the GCL2505-supplemented (N=69) and placebo (N=68) groups during the treatment period.
| Treatment period |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 week |
4 weeks |
8 weeks |
12 weeks |
||||||
| Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | ||
| Energy (kcal/day) | GCL2505 | 1,817 | 1,715, 1,919 | 1,853 | 1,737, 1,968 | 1,818 | 1,706, 1,931 | 1,845 | 1,724, 1,966 |
| Placebo | 1,876 | 1,768, 1,984 | 1,909 | 1,789, 2,029 | 1,914 | 1,812, 2,016 | 1,881 | 1,787, 1,974 | |
| Protein (g/day) | GCL2505 | 68.6 | 64.3, 72.9 | 69.3 | 65.0, 73.5 | 68.3 | 63.8, 72.9 | 69.0 | 64.5, 73.6 |
| Placebo | 70.8 | 66.5, 75.0 | 71.0 | 67.0, 75.0 | 72.1 | 67.6, 76.6 | 71.8 | 68.2, 75.5 | |
| Carbohydrate (g/day) | GCL2505 | 241.1 | 228.0, 254.2 | 242.3 | 226.3, 258.4 | 241.0 | 226.1, 255.9 | 241.7 | 224.5, 258.8 |
| Placebo | 252.9 | 237.5, 268.3 | 249.8 | 232.0, 267.7 | 251.9 | 236.4, 267.4 | 247.6 | 231.9, 263.3 | |
| Fat (g/day) | GCL2505 | 57.2 | 52.7, 61.8 | 60.9 | 56.2, 65.6 | 58.4 | 53.6, 63.1 | 60.2 | 55.0, 65.3 |
| Placebo | 58.6 | 54.2, 62.9 | 63.7 | 57.6, 69.8 | 62.4 | 58.4, 66.4 | 60.9 | 57.1, 64.7 | |
| Steps walked (counts/day) | GCL2505 | 7,206 | 6,552, 7,861 | 7,681 | 6,933, 8,430 | 7,696 | 6,870, 8,522 | 7,831 | 7,049, 8,613 |
| Placebo | 7,754 | 6,835, 8,674 | 8,175 | 7,080, 9,271 | 8,264 | 7,200, 9,328 | 8,048 | 7,037, 9,058 | |
Values are means and 95% confidence intervals (CIs).